Adverse drug effects Gastrointestinal tract bleeding, symptomatic gastrointestinal reflux, symptoms of congestive heart failure or ischaemic heart disease, sleep disturbance, fractures, depression · exacerbations of COPD
SCS treatment for 7 or fewer days showed no clear difference in adverse drug effects Gastrointestinal tract bleeding, symptomatic… compared with SCS treatment (low certainty).
1 finding from 1 review
All‐cause mortality · exacerbations of COPD
SCS treatment for 7 or fewer days showed no clear difference in mortality compared with SCS treatment (moderate certainty).
1 finding from 1 review
Length of hospitalisation (days) · exacerbations of COPD
1 finding from 1 review
FEV1 · exacerbations of COPD
1 finding from 1 review
QoL · exacerbations of COPD
1 finding from 1 review
Stone clearance · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers may leads to higher stone clearance compared with standard therapy (low certainty).
1 finding from 1 review
Pain episodes · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Dose of diclofenac (mg) · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Hospital admissions · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers showed no clear difference in hospitalisation compared with placebo (moderate certainty).
1 finding from 1 review
Surgical intervention · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers showed no clear difference in surgical intervention compared with placebo (high certainty).
1 finding from 1 review
Major adverse events · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers showed no clear difference in major adverse events compared with standard therapy (low certainty).
1 finding from 1 review
Pain episodes · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Dose of diclofenac · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Hospital admissions · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers probably leads to lower hospitalisation compared with standard therapy (moderate certainty).
1 finding from 1 review
Surgical intervention · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers showed no clear difference in surgical intervention compared with standard therapy (low certainty).
1 finding from 1 review
Stone clearance · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers probably leads to higher stone clearance compared with placebo (moderate certainty).
1 finding from 1 review
Major adverse events · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers probably leads to higher major adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Exacerbations · Adults (aged 40 or over) with COPD presenting with 1 or more exacerbations in the previous year. The 2 larger studies (Albert 2011; Sethi…
Antibiotics probably leads to lower number of people with one or more exacerbations WMD of compared with placebo (moderate certainty).
1 finding from 1 review
Annual Exacerbation Rates · Adults (aged 40 or over) with COPD presenting with 1 or more exacerbations in the previous year. The 2 larger studies (Albert 2011; Sethi…
Antibiotics probably leads to lower rate of exacerbation per patient/year WMD of compared with placebo (moderate certainty).
1 finding from 1 review
HRQoL: total score · Adults (aged 40 or over) with COPD presenting with 1 or more exacerbations in the previous year. The 2 larger studies (Albert 2011; Sethi…
1 finding from 1 review